AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 172.00
-1.50 (-0.86%)
May 8, 2026, 1:53 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 14.72 billion as of May 8, 2026. Its market cap has increased by 321.89% in one year.
Market Cap
14.72B
Enterprise Value
13.61B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
172.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 14.72B, an increase of 188.85%. That is a compound annual growth rate of 45.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 14.72B | -3.93% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 25.35B |
| Lumosa Therapeutics | 22.78B |
| Sunmax Biotechnology | 20.89B |
| Medigen Vaccine Biologics | 15.90B |
| Polaris Group | 15.52B |
| EirGenix | 13.95B |
| TaiMed Biologics | 13.36B |
| CHO Pharma | 12.24B |